Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Meta-analysis of utility values, including using the Bayesian Power Prior

Director, Anthony Hatswell, Delta Hat

External Seminars New Research Seminar Series Seminars

Tuesday, 30 April 2024, 2pm to 3pm

Hosted by The Health Economics Research Centre (HERC)

Date and time:  Tuesday 30 April 2024, 14:00 hours (2.00 pm UK GMT)

Location: L1 Main Meeting Room, Richard Doll Building, Old Road Campus, Headington, OX3 7LF

To Join: This is a free event, which will be taking place both in-person and online via Zoom/Microsoft Teams. Register

Abstract: Anthony Hatswell will present on meta-analysing utility values, and a recent paper showing how this can be done including weightings for beliefs on which study is more relevant – an approach known as the Bayesian Power Prior (BPP). The method is illustrated using 4 case studies, with the only prerequisite being a vague understanding of the aims of cost-utility analysis/evidence based medicine. The case studies are then analysing using the ‘preferred’ value, fixed- and random-effects meta analysis, and the BPP, with comparisons made, a re-analysis of the case studies, and then time for discussion on the subject more generally. No statistical knowledge is assumed or required.

Bio: Anthony is a statistician who works as director of Delta Hat (who specialise in technical evidence based medicine), and has an honorary research post at UCL. He previously spent 5 years on the NICE Interventional Procedures Committee, as well as having previously worked in the pharma industry before moving to consulting in 2010.

Forthcoming External Talks

OxTalks (Oxford Population Health)